| Mrs Rebecca Lyn Jehn, MPT,MHSA,OCS,FAAOMPT | |
|
600 Rodeo Dr, Erlanger, KY 41018-1279 | |
| (513) 354-3700 | |
| (513) 354-3705 |
| Full Name | Mrs Rebecca Lyn Jehn |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 27 Years |
| Location | 600 Rodeo Dr, Erlanger, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679699730 | NPI | - | NPPES |
| 7100220960 | Medicaid | KY | |
| K046440 | Other | MEDICARE PTAN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 004916 (Kentucky) | Primary |
| 225100000X | Physical Therapist | 008643 (Ohio) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Beacon Orthopaedics And Sports Medicine Ltd | 0345136412 | 438 |
| Beacon Orthopaedics And Sports Medicine Ltd | 0345136412 | 438 |
News Archive
Researchers have tied mutations in a gene that causes amyotrophic lateral sclerosis and other neurodegenerative disorders to the toxic buildup of certain proteins and related molecules in cells, including neurons. The research, published recently in the scientific journal Cell, offers a new approach for developing treatments against these devastating diseases.
People who delay or refuse vaccines for themselves or their children are presenting a growing challenge for countries seeking to close the immunization gap. Globally, 1 in 5 children still do not receive routine life-saving immunizations, and an estimated 1.5 million children still die each year of diseases that could be prevented by vaccines that already exist, according to WHO.
Genta Incorporated (OTCBB: GNTA) announced today that the Company has closed a second tranche of a previously announced offering with institutional investors to place Units consisting of 30% of Common Stock and 70% of Unsecured Subordinate Convertible Notes totaling $7 million in gross proceeds before fees and expenses.
More than half of patients with relapsed multiple myeloma treated with carfilzomib experienced cardiac issues during treatment, according to a multi-institutional study published June 12 in Journal of Clinical Oncology.
Rheumatoid arthritis patients treated with biologic response modifiers for at least 6 months do not have a greater risk for malignancy than those given other disease-modifying drugs or placebo, conclude US and Spanish researchers.
› Verified 4 days ago
| Provider Name | Beacon Orthopaedics & Sports Medicine Ltd |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1386670065 PECOS PAC ID: 0345136412 Enrollment ID: O20131105001048 |
News Archive
Researchers have tied mutations in a gene that causes amyotrophic lateral sclerosis and other neurodegenerative disorders to the toxic buildup of certain proteins and related molecules in cells, including neurons. The research, published recently in the scientific journal Cell, offers a new approach for developing treatments against these devastating diseases.
People who delay or refuse vaccines for themselves or their children are presenting a growing challenge for countries seeking to close the immunization gap. Globally, 1 in 5 children still do not receive routine life-saving immunizations, and an estimated 1.5 million children still die each year of diseases that could be prevented by vaccines that already exist, according to WHO.
Genta Incorporated (OTCBB: GNTA) announced today that the Company has closed a second tranche of a previously announced offering with institutional investors to place Units consisting of 30% of Common Stock and 70% of Unsecured Subordinate Convertible Notes totaling $7 million in gross proceeds before fees and expenses.
More than half of patients with relapsed multiple myeloma treated with carfilzomib experienced cardiac issues during treatment, according to a multi-institutional study published June 12 in Journal of Clinical Oncology.
Rheumatoid arthritis patients treated with biologic response modifiers for at least 6 months do not have a greater risk for malignancy than those given other disease-modifying drugs or placebo, conclude US and Spanish researchers.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Rebecca Lyn Jehn, MPT,MHSA,OCS,FAAOMPT 600 Rodeo Dr, Erlanger, KY 41018-1279 Ph: (513) 354-3700 | Mrs Rebecca Lyn Jehn, MPT,MHSA,OCS,FAAOMPT 600 Rodeo Dr, Erlanger, KY 41018-1279 Ph: (513) 354-3700 |
News Archive
Researchers have tied mutations in a gene that causes amyotrophic lateral sclerosis and other neurodegenerative disorders to the toxic buildup of certain proteins and related molecules in cells, including neurons. The research, published recently in the scientific journal Cell, offers a new approach for developing treatments against these devastating diseases.
People who delay or refuse vaccines for themselves or their children are presenting a growing challenge for countries seeking to close the immunization gap. Globally, 1 in 5 children still do not receive routine life-saving immunizations, and an estimated 1.5 million children still die each year of diseases that could be prevented by vaccines that already exist, according to WHO.
Genta Incorporated (OTCBB: GNTA) announced today that the Company has closed a second tranche of a previously announced offering with institutional investors to place Units consisting of 30% of Common Stock and 70% of Unsecured Subordinate Convertible Notes totaling $7 million in gross proceeds before fees and expenses.
More than half of patients with relapsed multiple myeloma treated with carfilzomib experienced cardiac issues during treatment, according to a multi-institutional study published June 12 in Journal of Clinical Oncology.
Rheumatoid arthritis patients treated with biologic response modifiers for at least 6 months do not have a greater risk for malignancy than those given other disease-modifying drugs or placebo, conclude US and Spanish researchers.
› Verified 4 days ago
Peter M Johnson, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 600 Rodeo Dr, Erlanger, KY 41018 Phone: 513-815-5585 Fax: 859-342-0079 | |
Kelci Dee Lange, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 600 Rodeo Dr, Erlanger, KY 41018 Phone: 513-815-5585 Fax: 859-342-0079 | |
Dr. Jolene M Foster, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 3869 Deertrail Dr, Erlanger, KY 41018 Phone: 484-866-5333 | |
Brian Muff, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 600 Rodeo Dr, Erlanger, KY 41018 Phone: 513-815-5585 Fax: 859-342-0079 | |
Johannah M Sorrell, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 600 Rodeo Dr, Erlanger, KY 41018 Phone: 513-815-5585 Fax: 859-342-0079 | |
Kristen Schellhaas, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 600 Rodeo Dr, Erlanger, KY 41018 Phone: 513-815-5585 Fax: 859-342-0079 | |
Keaton A Hagins, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 600 Rodeo Dr, Erlanger, KY 41018 Phone: 513-815-5585 Fax: 859-342-0079 |